PRRT2 and hypertensive disorder: HTN, coronary and cerebral vasospasm, and certain forms of CAD that do not respond adequately to Ca2+ antagonists may be more sensitive to other treatment modalities that target Ca2+ sensitization pathways, including PKC and ROCK [20,47,302,455,456].